Literature DB >> 25199052

Western diet in ApoE-LDLR double-deficient mouse model of atherosclerosis leads to hepatic steatosis, fibrosis, and tumorigenesis.

Marian Kampschulte1, Christiane Stöckl1, Alexander C Langheinrich2, Ulrike Althöhn1, Rainer M Bohle3, Gabriele A Krombach1, Philipp Stieger4, Yuri Churin5, Sandra Kremer5, Christian Dierkes6, Timo Rath7, Elke Roeb5, Martin Roderfeld5.   

Abstract

Nonalcoholic fatty liver disease has been linked to cardiovascular diseases and atherosclerosis. The aim of the current study was to characterize the hepatic pathology leading to fibrosis and tumors in a murine model of atherosclerosis. Male apolipoprotein E/low-density lipoprotein receptor double-knockout mice (AL) mice were fed with a high fat and high cholesterol western diet for 35 weeks (AL mice on WD). Protein and mRNA analysis as well as micro-computed tomography (micro-CT) were performed to assess oxidative stress, liver damage, inflammation, fibrosis, signaling pathways, vascularization, and tumorigenesis. Controls were chosen to distinguish between genetically and dietary effects in steatohepatitis and associated tumorigenesis. Hepatic inflammation and dyslipidemia were increased in AL mice on WD compared with wild-type mice on WD. Uniquely, AL mice on WD showed a spontaneous development of tumors (30% of cases) and thickening of intrahepatic vessel walls. Functionally relevant underlying signaling pathways such as NF-κB, Stat3, JNK, and AKT were differentially regulated between AL and wild-type mice on WD. Micro-CT was capable of visualizing and quantitatively distinguishing tumor neovascularization from vascularization in non-neoplastic liver tissue. AL mice on WD diet represent a novel model combining atherosclerosis and nonalcoholic fatty liver disease. Signaling pathways of liver cell damage and compensatory liver regeneration in combination with enhanced inflammation appear to be crucial for the spontaneous development of tumors in AL mice on WD. Micro-CT represents a new and powerful technique for the ultrastructural and three-dimensional assessment of the vascular architecture of liver tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199052     DOI: 10.1038/labinvest.2014.112

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  38 in total

1.  Epidemiology and natural history of non-alcoholic steatohepatitis.

Authors:  Curtis K Argo; Stephen H Caldwell
Journal:  Clin Liver Dis       Date:  2009-11       Impact factor: 6.126

Review 2.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

3.  Three-dimensional distribution of mineral in bone at a resolution of 15 micron determined by x-ray microtomography.

Authors:  J C Elliott; S D Dover
Journal:  Metab Bone Dis Relat Res       Date:  1984

4.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

Authors:  G S Herron; M J Banda; E J Clark; J Gavrilovic; Z Werb
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

5.  Factors associated with use of ultrasonography screening for hepatocellular carcinoma among hepatitis B or C carriers.

Authors:  Eo Rin Cho; Aesun Shin; Kui Son Choi; Hoo-Yeon Lee; Jeongseon Kim
Journal:  Cancer Epidemiol       Date:  2010-10-13       Impact factor: 2.984

Review 6.  NF-kappaB inhibition: a double-edged sword in cancer?

Authors:  Eli Pikarsky; Yinon Ben-Neriah
Journal:  Eur J Cancer       Date:  2006-03-10       Impact factor: 9.162

7.  Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice.

Authors:  Martin Roderfeld; Timo Rath; Robert Voswinckel; Christian Dierkes; Hartmut Dietrich; Daniel Zahner; Jürgen Graf; Elke Roeb
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

8.  Quantifying hepatic steatosis - more than meets the eye.

Authors:  Adam P Levene; Hiromi Kudo; Matthew J Armstrong; Mark R Thursz; Wladyslaw M Gedroyc; Quentin M Anstee; Robert D Goldin
Journal:  Histopathology       Date:  2012-02-28       Impact factor: 5.087

9.  Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

Authors:  Matthew J Armstrong; Diarmaid D Houlihan; Louise Bentham; Jean C Shaw; Robert Cramb; Simon Olliff; Paramjit S Gill; James M Neuberger; Richard J Lilford; Philip N Newsome
Journal:  J Hepatol       Date:  2011-05-18       Impact factor: 25.083

10.  Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease.

Authors:  Satoru Matsuda; Mayumi Kobayashi; Yasuko Kitagishi
Journal:  ISRN Endocrinol       Date:  2013-01-30
View more
  13 in total

Review 1.  Inflammatory Mechanisms of Diabetes and Its Vascular Complications.

Authors:  Lyudmila V Nedosugova; Yuliya V Markina; Leyla A Bochkareva; Irina A Kuzina; Nina A Petunina; Irina Y Yudina; Tatiana V Kirichenko
Journal:  Biomedicines       Date:  2022-05-18

2.  Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.

Authors:  Guang-Hua Tang; Hua-Yu Yang; Jin-Chun Zhang; Jin-Jun Ren; Xin-Ting Sang; Xin Lu; Shou-Xian Zhong; Yi-Lei Mao
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 3.  Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy.

Authors:  Qing-Qing Zhang; Lun-Gen Lu
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

4.  Quercetin Alleviates High-Fat Diet-Induced Oxidized Low-Density Lipoprotein Accumulation in the Liver: Implication for Autophagy Regulation.

Authors:  Liang Liu; Chao Gao; Ping Yao; Zhiyong Gong
Journal:  Biomed Res Int       Date:  2015-12-01       Impact factor: 3.411

5.  Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis.

Authors:  Robert Schierwagen; Lara Maybüchen; Sebastian Zimmer; Kanishka Hittatiya; Christer Bäck; Sabine Klein; Frank E Uschner; Winfried Reul; Peter Boor; Georg Nickenig; Christian P Strassburg; Christian Trautwein; Jogchum Plat; Dieter Lütjohann; Tilman Sauerbruch; Frank Tacke; Jonel Trebicka
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

6.  Gαi3-Dependent Inhibition of JNK Activity on Intracellular Membranes.

Authors:  Guillaume Bastin; Jin Ye Yang; Scott P Heximer
Journal:  Front Bioeng Biotechnol       Date:  2015-09-01

7.  A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.

Authors:  Thomas Bertero; Katherine A Cottrill; Sofia Annis; Balkrishen Bhat; Bernadette R Gochuico; Juan C Osorio; Ivan Rosas; Kathleen J Haley; Kathleen E Corey; Raymond T Chung; B Nelson Chau; Stephen Y Chan
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

8.  Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice.

Authors:  Yasodha Krishnasamy; Venkat K Ramshesh; Monika Gooz; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

9.  Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions.

Authors:  Anna-Katharina Wernicke; Yuri Churin; Diana Sheridan; Anita Windhorst; Annette Tschuschner; Stefan Gattenlöhner; Martin Roderfeld; Elke Roeb
Journal:  Oncotarget       Date:  2016-11-08

Review 10.  Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models.

Authors:  Ángela Vinué; Andrea Herrero-Cervera; Herminia González-Navarro
Journal:  Nutrients       Date:  2018-07-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.